Synthesis and bioevaluation of glycosyl ureas as α-glucosidase inhibitors and their effect on mycobacterium

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 13, 2003, Pages 2911-2922

  Tewari, Neetu ^a   Tiwari, V K ^a   Mishra, R C ^a   Tripathi, R P ^a   Srivastava, A K ^a   Ahmad, R ^a   Srivastava, R ^a   Srivastava, B S ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; DIHYDROPYRIMIDINONE; ESTER DERIVATIVE; ETHYL [3 O 5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 5 (N 1 CYCLOPROPYL N 3 BENZYL)(1 UREIDYL) 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [3 O BENZYL 5, 6 DIDEOXY 1,2 O ISOPROPYLIDENE 5 (N 1 DODECYL N 3 BENZYL 1 UREIDYL) 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [3 O BENZYL 5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 5 (N 1 OLEYL N 3 BENZYL 1 UREIDYL) 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [3 O BENZYL 5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 5 [N 1 BUTYL N 3 (4 FLUOROPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [3 O BENZYL 5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 5 [N 1 CYCLOPROPYL N 3 (3 ACETYLPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [3 O BENZYL 5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 5 [N 1 CYCLOPROPYL N 3 (4 CHLOROPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [3 O BENZYL 5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 5 [N 1 DODECYL N 3 (3 ACETYLPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [3 O BENZYL 5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 5 [N 1 DODECYL N 3 (4 CHLOROPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [3 O BENZYL 5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 5 [N 1 DODECYL N 3 (4 FLUOROPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [3 O BENZYL 5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 5 [N 3 (4 CHLOROPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [5,6 DIDEOXY 1, 2 O ISOPROPYLIDENE 3 O METHYL 5 [N 3 (4 CHLOROPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [5,6 DIDEOXY 1,2 ISOPROPYLIDENE 3 O METHYL 5 (N 1 HEPTYL N 3 BENZYL 1 UREIDYL) 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 3 O METHYL 5 (N 1 CYCLOPROPYL N 3 BENZYL 1 UREIDYL) 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 3 O METHYL 5 (N 1 HEXADECYL N 3 PHENYL) 1 UREIDYL 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 3 O METHYL 5 (N 1 OLEYL N 3 BENZYL) 1 UREIDYL 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 3 O METHYL 5 [N 1 BUTYL N 3 (4 FLUOROPHENYL 1 UREIDYL) 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 3 O METHYL 5 [N 1 BUTYL N 3 (4 FLUOROPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 3 O METHYL 5 [N 1 CYCLOPROPYL N 3 (4 CHLOROPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 3 O METHYL 5 [N 1 DODECYL N 3 (4 CHLOROPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; ETHYL [5,6 DIDEOXY 1,2 O ISOPROPYLIDENE 3 O METHYL 5 [N 1 HEXADECYL N 3 (4 CHLOROPHENYL) 1 UREIDYL] 1,4 HEPTOFURANOS 5 YL]URONOATE; GLYCOSYL AMINO ESTER; GLYCOSYL UREA; INTESTINE ENZYME; ISOCYANIC ACID DERIVATIVE; PYRIMIDINONE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMIDATION; ANTIBACTERIAL ACTIVITY; ARTICLE; CHEMICAL PROCEDURES; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM; NONHUMAN;

MYCOBACTERIUM; MYCOBACTERIUM AURUM;

EID: 0037871689     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00214-1     Document Type: Article

References (43)

1. (a) Kingh H., Aubert R.E., Herman W.H. Diabetes Care. 21:1998;1414
2. (b) Harris M.I., Flegal K.M., Cowie C.C., Eberherdt M.S., Goldstein D.E., Little R.K., Wiedmeyer H.M., Byrd-Holt D.D. Diabetes Care. 21:1998;518.
3. (a) Pablos M.A., Raviglione M.C.L. N. Engl. J. Med. 338:1998;1641
4. (b) Zimmet P. J. Intern. Med. 247:2000;301
5. (c) Zimmet P. Diabetologia. 42:1999;499
6. (d) Groop L. J. Intern. Med. 241:1997;95
7. (e) Huebner R.E., Castro K.G. Ann. Rev. Med. 46:1995;47.
8. Lebovitz H.E. Drugs. 44(Suppl. 3):1992;21.
9. Gale E.A.M. Lancet. 357:2001;1870.
10. Moller D.E. Nature. 414:2001;821.
11. Emst E. Br. J. Med. 321:2000;395.
12. (a) Paulsen H., Todt K. Adv. Cabohydr. Chem. 23:1968;115
13. (b) Fellows L.E. Chem. Br. 23:1987;842
14. (c) Truscheit E., Frommer W., Junge B., Muller L., Schmidt D., Wingender W. Angew. Chem., Int. Ed. Engl. 20:1981;744
15. (d) Inouge S., Tsuruoka T., Ito A., Niida T. Tetrahedron. 24:1968;2125
16. (e) Muller, L. In Biotechnology; Rehn, H. J., Reed, G., Eds., VCH: Weinheim, 1985; Vol. 4, Chapter 18.
17. Bayer A.G., Kinast G., Schuller M., Schroder T., Ger Offen D.R., Anzeveno P.B., Creemer L.J., Daniel J.K., King C.H.R., Liu P.S. J. Org. Chem. 54:1989;2539 Yoshikuni Y., Ezure Y., Aoyagi Y., Enomoto H. J. Pharmacobiol. Dyn. 111:1988;356.
18. Bayer A.G., Kinast G., Schuller M., Schroder T., Ger Offen D.R., Anzeveno P.B., Creemer L.J., Daniel J.K., King C.H.R., Liu P.S. J. Org. Chem. 54:1989;2539 Yoshikuni Y., Ezure Y., Aoyagi Y., Enomoto H. J. Pharmacobiol. Dyn. 111:1988;356.
19. (a) Karpus A., Fleet G.W.J., Dwek R.A., Petursson S., Namgoong S.K., Ramsden N.G., Jacob G.S., Rademacher T.W. J. Proc. Natl. Acad. Sci. U.S.A. 85:1988;9229
20. (b) Walker B.D., Kowalski M., Goh W.C., Kozarsky K., Krieger M., Rosen C., Rohrschneider L., Haseltine W.A., Sodroski. J. Proc. Natl. Acad. Sci. U.S.A. 84:1987;8120
21. (c) Winkler D.A., Holan G. J. Med. Chem. 32:1989;2084.
22. Evans S.V., Fellows L.E., Shing K.T.M., Flee G.WJ. Phytochemistry. 24:1985;1953.
23. Humphries M.J., Matsumoto K., White S.L., Olden K. Cancer Res. 46:1986;5215.
24. Bischoff H. Eur. J. Clin. Invest. 24:1994;3.
25. Toeller M. Eur. J. Clin. Invest. 24:1994;31.
26. Porus J.R. Drugs Future. 11:1986;729.
27. Bayer A.G. Drugs Future. 11:1986;1039.
28. Kajimoto T., Liu K.K.C., Pederson R.L., Zhong Z., Ichikawa Y., John A., Porco, Wong C.H. Jr. J. Am. Chem. Soc. 113:1991;6187. and references cited therein.
29. Frank S. Angew. Chem., Int. Ed. 41:2002;230.
30. Scozzafava A., Mastrolorenzo A., Suparan C.T. J. Enzyme Inhib. 16:2001;425.
31. Fischer J.F., Harrison A.W., Bundy G.L., Wilkinson K.F., Rush B.D., Ruwart M.J. J. Med. Chem. 34:1991;3140.
32. Negre J., Chance M.L., Hanboula S.Y., Monsigny M., Roche A.C., Mayer R.M., Hommel M. Antimicrob. Agents Chemother. 36:1992;2228.
33. (a) Tiwari V.K., Tripathi R.P. Indian J. Chem. 41B:2002;1681
34. (b) Tripathi R.P., Tripathi R., Tiwari V.K., Bala L., Sinha S., Srivastava A., Srivastava R., Srivastava B.S. Eu. J. Med. Chem. 37:2002;773
35. (c) Khan A.R., Tripathi R.P., Tiwari V.K., Mishra R.C., Reddy V.J.M.J.K.Saxena J. Carbohyd, Chem. 21:2002;587
36. (d) Mishra R.C., Tewari N., Arora K., Ahmad R., Tripathi R.P., Tiwari V.K., Walter R.D., Srivatava A.K. Comb. Chem. Highthroughtput Screen. 6:2003;37
37. (e) Tewari N., Mishra R.C., Tiwari V.K., Tripathi R.P. Synlett. 11:2002;1779.
38. Patil N.T., Tilekar J.N., Dhavale D.D. J. Org. Chem. 66:2001;1065.
39. Hirama M., Shigemoto T., Yamazaki Y., Ito S. J. Am. Chem. Soc. 107:1985;1797.
40. Hanson R.L., Ho R.S., Wiseberg J.J., Simpson R., Younathan E.S., Blair J.B. J. Biol. Chem. 259:1984;218.
41. Cogoli A., Mosimann H., Vock C., Balthazar A.K.V., Semenza G. Eur. J. Biochem. 30:1972;7.
42. Matsui T., Yoshimoto S., Osajima K., Oki T., Osajima Y. Biosci. Biotech. Biochem. 60:1996;2019.
43. Deb D.K., Srivastava K.K., Srivastava R., Srivastava B.S. Biochem. Biophys. Res. Commun. 279:2000;457.